Clinical researchers could avoid the bulk of FDA inspection issues that might impact their organization by following study protocols to the letter and making sure documentation and record-keeping practices are beyond reproach. But that’s easier said than done. The growing complexity of clinical trials, ever-expanding data points, new management technologies and differing experience levels among staff all combine to make this a challenge.